MPV tends to hit hardest in young children, older adults and people with weakened immune systems. A virologist explains.

Human Metapneumovirus (hMPV) is a respiratory virus that can cause cold-like symptoms, bronchitis, or pneumonia, particularly in young children, older adults, and immunocompromised individuals.

As the concerns over the Human Metapneumovirus (HPMV) virus grows, a 56-year-old woman patient was found to be infected with the HMPV virus by "Charak Hospital".

Human Metapneumovirus: "There has indeed been a rise in a number of common respiratory infections in the country. And this is entirely expected during the winter. China has a sentinel surveillance ...

The human metapneumovirus (hMPV) is not new in China or elsewhere in the world, its recent spike in China is within the usual range for winter and there is no evidence that China has declared a ...

Human Metapneumovirus (HMPV) is an emerging respiratory virus that has gained attention all around the globe. It can lead to a variety of illnesses, particularly in vulnerable groups such as ...

1:54 Spiking cases of human metapneumovirus in China not a major threat: WHO. WATCH: Cases of a type of human metapneumovirus are surging in China, which is making headlines in a post-Covid-19 world.

Human Metapneumovirus has been detected worldwide. In temperate regions, infections peak in late winter or early spring, often overlapping with other respiratory viruses such as influenza and RSV.

Cases of a type of human metapneumovirus are surging in China, which is making headlines in a post-Covid-19 world. But as Katherine Ward reports, doctors say there is no reason to panic, and ...

A boy receives nebulizer treatment in Srinagar, Jammu and Kashmir, India, Jan. 7, 2025, as the Indian Council of Medical Research confirmed the country's first cases of the human metapneumovirus ...

Human metapneumovirus, or hMPV, was first identified 24 years ago by a group of Dutch scientists seeking to better characterize viruses responsible for acute respiratory infections.

“On January 6, 2025, the NCDC, in collaboration with the Federal Ministry of Health and partners conducted a dynamic risk assessment for Human Metapneumovirus (HMPV).